Target Name: MIR6825
NCBI ID: G102466199
Review Report on MIR6825 Target / Biomarker Content of Review Report on MIR6825 Target / Biomarker
MIR6825
Other Name(s): hsa-miR-6825-3p | hsa-mir-6825 | hsa-miR-6825-5p | microRNA 6825 | MicroRNA 6825

MIR6825: A Potential Drug Target and Biomarker

MIR6825 (hsa-miR-6825-3p) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and expression pattern have made it an attractive target for researchers to study and develop new treatments.

MIR6825 is a microRNA (miRNA), a small non-coding RNA molecule that plays a crucial role in post-transcriptional gene regulation. miRNAs have been shown to have a wide range of functions, including regulating cell growth, cell differentiation, and cell survival. They also play a key role in the development and progression of diseases, including cancer.

One of the key features of MIR6825 is its expression pattern. MIR6825 is highly expressed in various tissues and organs, including the brain, heart, liver, and pancreas. It is also expressed in various cell types, including cancer cells. This makes it an attractive target for researchers to study the effects of drugs on these cells and tissues.

Another feature of MIR6825 is its structure. MIR6825 has a unique structure that consists of 19 non-coding RNA bases. Its length is 29.5 nucleotides, and it has a high conservation score, which indicates that it is stable and has a long history of evolution. This structure makes it an ideal candidate for use as a drug target or biomarker.

In addition to its expression pattern and structure, MIR6825 has also been shown to play a key role in the development and progression of diseases. Studies have shown that MIR6825 is involved in the regulation of various cellular processes, including cell growth, apoptosis (programmed cell death), and inflammation. It has also been shown to be involved in the development of various diseases, including cancer.

One of the most promising aspects of MIR6825 is its potential as a drug target. MIR6825 has been shown to be involved in the regulation of various cellular processes, including cell growth, apoptosis, and inflammation. This makes it an attractive target for researchers to develop new treatments for these diseases.

MIR6825 has also been shown to have a unique expression pattern in various tissues and organs. Its high expression in cancer cells makes it an attractive target for researchers to study the effects of drugs on these cells and to identify new biomarkers for cancer.

In conclusion, MIR6825 is a non-coding RNA molecule that has a unique structure and expression pattern. Its high conservation score and its involvement in various cellular processes make it an attractive target for researchers to study the effects of drugs on various tissues and organs. Its potential as a drug target and biomarker make it an exciting area of research for the development of new treatments for various diseases.

Protein Name: MicroRNA 6825

The "MIR6825 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR6825 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR6826 | MIR6827 | MIR6828 | MIR6829 | MIR6830 | MIR6831 | MIR6832 | MIR6833 | MIR6834 | MIR6836 | MIR6837 | MIR6839 | MIR6840 | MIR6841 | MIR6842 | MIR6843 | MIR6844 | MIR6845 | MIR6846 | MIR6847 | MIR6848 | MIR6849 | MIR6850 | MIR6851 | MIR6852 | MIR6853 | MIR6854 | MIR6855 | MIR6856 | MIR6857 | MIR6858 | MIR6859-1 | MIR6859-2 | MIR6859-3 | MIR6859-4 | MIR6860 | MIR6861 | MIR6862-1 | MIR6862-2 | MIR6863 | MIR6864 | MIR6865 | MIR6866 | MIR6867 | MIR6868 | MIR6869 | MIR6870 | MIR6871 | MIR6872 | MIR6873 | MIR6874 | MIR6875 | MIR6876 | MIR6877 | MIR6878 | MIR6879 | MIR6880 | MIR6881 | MIR6882 | MIR6883 | MIR6884 | MIR6885 | MIR6886 | MIR6887 | MIR6888 | MIR6889 | MIR6890 | MIR6891 | MIR6892 | MIR6893 | MIR6894 | MIR6895 | MIR7-1 | MIR7-2 | MIR7-3 | MIR7-3HG | MIR708 | MIR7106 | MIR7107 | MIR7108 | MIR7109 | MIR711 | MIR7110 | MIR7111 | MIR7112 | MIR7113 | MIR7114 | MIR7150 | MIR7151 | MIR7152 | MIR7153 | MIR7154 | MIR7155 | MIR7156 | MIR7158 | MIR7159 | MIR7160 | MIR7161 | MIR7162 | MIR718